-
GRIP Extra: DHS investigates ex-CISA director Krebs, Atkins in as SEC chair
Other news includes a whistleblower testifying that Facebook was working with CCP on censorship, Treasury announcing the rollback of 15 rules and guidance statements, and the publication of several ESMA documents.
-
DOJ moves forward with Smartmatic FCPA case, despite Trump EO
The DOJ said it will continue to prosecute executives at the voting machine company Smartmatic Corp. for FCPA and AML violations.
-
Assessing the role, value and cost of compliance monitors
Compliance monitorships are costly and burdensome, and sometimes an effective way to achieve critical business objectives.
-
DOJ ends energy giant Glencore’s monitorship early
DOJ attorneys in court documents said they were using their “sole discretion” under a plea agreement with Glencore to “terminate the monitorship early.”
-
Podcast: Denis Jacob charts a path through regulatory uncertainty for healthcare
As leader of the ethics and compliance program at Henry Schein, Jacobs collaborates with stakeholders to ensure compliance, while prioritizing growth.
-
Regulatory uncertainty brings risk and opportunity to pharma in 2025, says Jeff Lemay
CCO Jeff Lemay reflects on his time at Jazz Pharmaceuticals and asseses the road ahead for compliance and legal teams in the pharma sector.
-
Suspending the FCPA will complicate global anti-corruption work
Will UK and Europe step up to the plate after Trump’s suspension of crucial anti-corruption legislation, asks Tony McClements?
-
FCPA trial almost started, but DOJ’s suspension of new FCPA cases lingers
The FCPA enforcement action against Cognizant is going forward despite President Trump’s Executive Order.